Clinical trial / 2013
Oral limonene accumulated in breast tissue and reduced tumor cyclin D1 expression.
Forty-three women with newly diagnosed operable breast cancer took 2 grams of limonene daily for 2 to 6 weeks before surgical resection. Limonene preferentially concentrated in breast tissue, reaching a mean level of 41.3 µg/g, and led to a 22% reduction in tumor cyclin D1 expression (p = 0.002). Circulating IGF-I increased slightly, while tissue Ki67, cleaved caspase-3, leptin, adiponectin, and IL-6 showed no significant alterations.
- Study type
- Open-label clinical trial
- Who was studied
- 43 women with newly diagnosed operable breast cancer
- What was measured
- Breast tissue limonene concentration and tumor biomarker expression
THE PAPER
Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer.
Miller JA, Lang JE, Ley M, Nagle R, Hsu CH, Thompson PA, Cordova C, Waer A, Chow HH. Cancer Prev Res (Phila), 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.